The Safety and Efficacy of MK-1293 Versus Lantus™ in Participants With Type 2 Diabetes Mellitus (MK-1293-006)
Clinical trial NCT02059187 · COMPLETED
Trial details
- NCT number
- NCT02059187
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-11
- Primary completion
- 2015-03-11
- Enrollment
- 531
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.